🇺🇸 FDA
Patent

US 9340547

Pyrrolotriazinone derivatives as inhibitors P13K

granted A61KA61K31/53A61K45/06

Quick answer

US patent 9340547 (Pyrrolotriazinone derivatives as inhibitors P13K) held by Almirall, S.A. expires Mon May 12 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Almirall, S.A.
Grant date
Tue May 17 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 12 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/53, A61K45/06, A61P, A61P1/00